Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1523 Records) |
| Query Trace: CYP3A5[original query] |
|---|
| Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study. NPJ breast cancer 2024 9 10 (1): 84. Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung, Keith T Schmidt, Ming Tan, Ami Chitalia, Nanette H Bishopric, Seth Steinberg, Hyoyoung Choo-Wosoba, Giulia Napoli, Christopher Gallagher, Nadia Ashai, Kristen Whitaker, Candace Mainor, Shruti Tiwari, Nicole Swanson, Stacy Malloy, Claudine Isaacs, William Douglas Figg, Sandra M Swa |
| Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka. Human genomics 2024 9 18 (1): 107. Priyanga Ranasinghe, Chiranthi Liyanage, Nirmala Sirisena, Sandamini Liyanage, C D Nelanka Priyadarshani, D P Bhagya Hendalage, Vajira H W Dissanaya |
| Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital. Diseases (Basel, Switzerland) 2024 9 12 (9): . Sudhir Mehta, Krishna Mohan Medicherla, Sandhya Gulati, Nidhi Sharma, Rabia Parveen, Ashwani Kumar Mishra, Sonal Gupta, Prashanth Suravajha |
| Effect of CYP 3A4*1B and CYP3A5*3 Gene Polymorphisms in Antirejection of Tacrolimus in Liver Transplant Patients. Transplantation proceedings 2024 12 . Xia Zhou, Rujia Tang, Dali Zhang, Xi He, Zhenwen Liu, Yinjie Gao, Hongling L |
| [Glucocorticoid-resistant forms of endocrine ophthalmopathy]. Vestnik oftalmologii 2024 12 140 (6): 125-130. A F Brovki |
| Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals. Scientific reports 2024 12 14 (1): 30683. Jittima Piriyapongsa, Supatat Chumnumwat, Pavita Kaewprommal, Kwankom Triparn, Supharat Suvichapanich, Wanvisa Udomsinprasert, Jiraphun Jittikoon, Philip J Shaw, Vorthunju Nakhonsri, Chumpol Ngamphiw, Pongsakorn Wangkumhang, Manop Pithukpakorn, Ekkapong Roothumnong, Supakit Wiboonthanasarn, Chulaluck Kuptanon, Natini Jinawath, Thantrira Porntaveetus, Prapat Suriyaphol, Vip Viprakasit, Prapaporn Pisitkun, Piranit Kantaputra, Thipwimol Tim-Aroon, Duangrurdee Wattanasirichaigoon, Thanyachai Sura, Kanya Suphapeetiporn, Orapan Sripichai, Apichai Khongphatthanayothin, Suthat Fucharoen, Nuttapong Ngamphaiboon, Vorasuk Shotelersuk, Surakameth Mahasirimongkol, Sissades Tongsi |
| Allelic variants in xenobiotic metabolism genes predict susceptibility and worse prognosis of urothelial bladder cancer. Pathology, research and practice 2024 12 266 155767. Isabely Mayara da Silva, Flora Troina Maraslis, Julia Ayumi Ikeda Kawasaki, Natieli Kazue Aida, Gustavo Rafael Mazzaron Barcelos, Alexsandro Koike, Paulo Emílio Fuganti, Ilce Mara de Syllos Cólus, Roberta Losi Guembarovski, Juliana Mara Serpelo |
| GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA. Georgian medical news 2024 12 (355): 99-103. K Kovaleva, Z Kachiyeva, A Abetova, N Raspopo |
| Effects of CYP3A5 polymorphism and renal impairment on the drug interaction between venetoclax and fluconazole in acute myeloid leukaemia patients. Xenobiotica; the fate of foreign compounds in biological systems 2024 12 1-11. Takahiro Kobayashi, Honami Sato, Yumiko Akamine, Yayoi Fukushi, Naoto Takahashi, Masatomo Miu |
| [Innovative Personalized Medicine for Immunosuppressive Drugs Based on Novel Control Theory of Pharmacokinetics]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2024 12 144 (12): 1075-1080. Naoki Yoshika |
| Sex and common germline variants impact the toxicity profile and pharmacokinetics of alectinib: a nation-wide cohort study in patients with ALK-positive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Niels Heersche, Daan A C Lanser, M Benthe Muntinghe-Wagenaar, Ma Ida Mohmaed Ali, Ezgi B Ulas, Tessa M A Trooster, Evert de Jonge, Esther Oomen-de Hoop, Marthe S Paats, Idris Bahce, Sander Croes, Lizza E L Hendriks, Anthonie J van der Wekken, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijssen, G D Marijn Veerm |
| Effect of CYP3A5*3 genotype on exposure and efficacy of quetiapine: A retrospective, cohort study. Journal of affective disorders 2024 11 . Yan Zhao, Yupei Hao, Ziyi Wang, Shuai Liu, Shizhao Yuan, Chunhua Zhou, Jing |
| Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis. Expert opinion on drug metabolism & toxicology 2024 11 1-16. Seenae Eum, Nicholas P Vernacchia, Nia Doughty, Sahar Mehrzad, Andrew H Talal, Fatemeh Chalabianloo, Evan D Kharas |
| French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten. Clinical pharmacology and therapeutics 2024 11 . Louis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier, Benjamin Hennart, Sarah Baklouti, Séverine Cunat, Paul Vilquin, Yves Medard, Elodie Gautier-Veyret, Clara Laffitte-Redondo, Céline Verstuyft, Abd El Kader Ait Tayeb, Vincent Haufroid, Julien Wils, Fabien Lamoureux, Alexandre Evrard, Julie Davaze-Schneider, Mouna Ben-Sassi, Nicolas Picard, Sylvie Quaranta, Estelle Ayme-Dietrich, |
| Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study. The pharmacogenomics journal 2024 11 24 (6): 37. Yue Li, Qing Wan, Jiaqi Wan, Xiong Xiao, Jinfang Hu, Xintong Yang, Fancong Kong, Jieyu Wang, Baoquan Song, Zhentao Li, Fei Li, Simei Ren, Hongwei Pe |
| Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer. Future science OA 2024 11 10 (1): 2428077. M Angeles Vaz-Salgado, Victor Albarran, Javier Pozas, Reyes Ferreiro, Vanessa Pachón, Federico Longo, Mercedes Rodriguez, Emma Barreto, Julie Ea |
| Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients. ACS pharmacology & translational science 2024 11 7 (11): 3429-3438. Rashmi J Hemani, Priyal M Chauhan, Ratika Srivastava, Nitiraj B Shete, Amit S Jojera, Shailesh M Soni, Sishir D Gang, Abhijit M Konnur, Umapati N Hegde, Hardik B Patel, Banibrata N Mukhopadhyay, Manan A Raval, Sachchida Nand Pand |
| CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin. European journal of medical research 2024 11 29 (1): 539. Mohammed G Maslub, Nur Aizati Athirah Daud, Mahasen A Radwan, Abubakar Sha'aban, Arafa G Ibrah |
| Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine-Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients. Clinical pharmacology and therapeutics 2024 10 . Yawen Yuan, Wenting Hu, Changcheng Chen, Ruen Yao, Shunguo Zhang, Xiao Zhu, Bulong Xu, Zhonghui Huang, Shengyuan Zhang, Xuexian Wang, Mei Zheng, Xiaohui Huang, Joseph F Standi |
| CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis. Pharmacogenetics and genomics 2024 10 . Jiaqi Wang, Amy L Pasternak, Simran Maggo, Rochelle Mindanao, Jenny Q Nguyen, Cynthia L Go |
| Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation. PeerJ 2024 10 12 e18360. Tao Zhang, Xiaorong Chen, Yuan Liu, Lei Zha |
| Drug-gene interactions in older patients with coronary artery disease. BMC geriatrics 2024 10 24 (1): 881. Shizhao Zhang, Chao Lv, Lisha Dong, Yangxun Wu, Tong Y |
| Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up. Medicina (Kaunas, Lithuania) 2024 10 60 (10): . Nur Ul Ain, Niaz Ali, Abid Ullah, Shakir Ullah, Shujaat Ahm |
| CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients. International journal of molecular sciences 2024 10 25 (20): . Julia Concha, Estela Sangüesa, María Pilar Ribate, Cristina B Garc |
| Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series. Frontiers in immunology 2024 10 15 1441620. Sara Gagno, Bianca Posocco, Marco Orleni, Eleonora Cecchin, Arianna Fumagalli, Michela Guardascione, Angela Buonadonna, Jerry Polesel, Fabio Puglisi, Giuseppe Toffoli, Erika Cecch |
| Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders. Drug metabolism and pharmacokinetics 2024 10 101027. Kenta Sakaguchi, Takafumi Naito, Kohei Hoshikawa, Yukari Miyadera, Hironari Tanaka, Emi Nakatsugawa, Takahisa Furuta, Ken Sugimoto, Junichi Kawaka |
| Effect of CYP3A5*3, ABCC2 C-24T, and ABCC2 C3972T Genetic Polymorphisms on Direct Cost of Kidney Transplant Recipients. Cureus 2024 10 16 (9): e69221. Chiau Ling Choong, Farida Islahudin, Mohd Makmor-Bakry, Nor Asyikin Mohd Tahir, Hin-Seng Wong, Rosnawati Yah |
| The impact of CYP3A5, NR1I2, and POR polymorphisms on tacrolimus dose-adjusted concentration and clinical outcomes in adult allogeneic haematopoietic stem cell transplantation. Xenobiotica; the fate of foreign compounds in biological systems 2025 1 1-9. Yuan Gao, Jingjing |
| Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users. Journal of cannabis research 2025 1 7 (1): 1. Jessica A Wright, Linda Huang, Basant E Katamesh, Siddhant Yadav, Abhinav Singla, Ann Vince |
| In-silico screening and analysis of missense SNPs in human CYP3A4/5 affecting drug-enzyme interactions of FDA-approved COVID-19 antiviral drugs. Scientific reports 2025 1 15 (1): 2153. Amro A Abdelazim, Mohamad Maged, Ahmed I Abdelmaksoud, Sameh E Hassane |
- Page last reviewed:Feb 1, 2024
- Content source: